News Release

In utero exposure to maternal COVID-19 vaccination and offspring neurodevelopment at 12 and 18 months

JAMA Pediatrics

Peer-Reviewed Publication

JAMA Network

About The Study: The results of this study including 2,261 and 1,940 infants ages 12 and 18 months, respectively, suggest that COVID-19 vaccination was safe during pregnancy from the perspective of infant neurodevelopment to 18 months of age. Additional longer-term research should be conducted to corroborate these findings and buttress clinical guidance with a strong evidence base. 

Authors: Eleni G. Jaswa, M.D., M.Sc., of the University of California, San Francisco, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamapediatrics.2023.5743)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2023.5743?guestAccessKey=b640ef49-59a9-40d9-867a-25a2e4e4ff5f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012224


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.